Literature DB >> 9570573

Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy.

W Chen1, M H Sayegh, S J Khoury.   

Abstract

Intrathymic injection of Ag induces Ag-specific tolerance in several clinically relevant experimental autoimmune and transplantation models. However, the exact mechanisms of acquired thymic tolerance in vivo remain unclear. We investigated the mechanisms of acquired thymic tolerance in mice that are transgenic for the TCR specific for peptide 323-339 of OVA. Intrathymic injection of OVA leads to apoptosis of thymocytes starting as early as 3 h after injection and persisting up to 7 days. Double positive thymocytes undergo apoptosis earlier than single positive thymocytes, and significantly higher percentages of double positive thymocytes ultimately die as compared with single positive cells. Apoptotic cells show decreased surface expression of CD4. In the periphery, T cells from intrathymically injected animals had suppressed proliferation and IL-2 production to OVA compared with T cells from control Ag-injected mice. We conclude that intrathymic injection of Ag induces apoptosis of immature thymocytes and a subpopulation of mature thymocytes and induces prolonged anergy in peripheral T cells in vivo. Understanding the mechanisms of acquired thymic tolerance may lead to development of novel clinical strategies to prevent autoimmune disease and transplant rejection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions.

Authors:  B Metzler; D C Wraith
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Mouse xenoantigens contribute to rat T-cell Vbeta repertoire generation in mixed xenogeneic bone marrow chimeras.

Authors:  Y Huang; S T Ildstad; M Neipp; H Shirwan
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

3.  The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.

Authors:  K Kishimoto; V M Dong; S Issazadeh; E V Fedoseyeva; A M Waaga; A Yamada; M Sho; G Benichou; H Auchincloss; M J Grusby; S J Khoury; M H Sayegh
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival.

Authors:  Steven R Duncan; Nickolas G Capetanakis; Brian R Lawson; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Overcoming immunological barriers in regenerative medicine.

Authors:  Johannes L Zakrzewski; Marcel R M van den Brink; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

6.  Immunomodulatory strategies prevent the development of autoimmune emphysema.

Authors:  Masayuki Hanaoka; Mark R Nicolls; Andrew P Fontenot; Donatas Kraskauskas; Douglas G Mack; Adelheid Kratzer; Jonas Salys; Vita Kraskauskiene; Nana Burns; Norbert F Voelkel; Laimute Taraseviciene-Stewart
Journal:  Respir Res       Date:  2010-12-16

7.  Transfer of in vivo primed transgenic T cells supports allergic lung inflammation and FIZZ1 and Ym1 production in an IL-4Rα and STAT6 dependent manner.

Authors:  Preeta Dasgupta; Svetlana P Chapoval; Elizabeth P Smith; Achsah D Keegan
Journal:  BMC Immunol       Date:  2011-10-20       Impact factor: 3.615

8.  Requirement for transforming growth factor beta1 in controlling T cell apoptosis.

Authors:  W Chen; W Jin; H Tian; P Sicurello; M Frank; J M Orenstein; S M Wahl
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

9.  Bacterial clearance reverses a skewed T-cell repertoire induced by Salmonella infection.

Authors:  Jessica P Leyva-Rangel; Maria de Los Angeles Hernández-Cueto; Carlos-Samuel Galan-Enriquez; Marcela López-Medina; Vianney Ortiz-Navarrete
Journal:  Immun Inflamm Dis       Date:  2015-05-06

Review 10.  Immune Tolerance Therapy: A New Method for Treatment of Traumatic Brain Injury.

Authors:  Ruo-Yang Feng; Qian Chen; Wei-Jian Yang; Xiao-Guang Tong; Zhi-Ming Sun; Hua Yan
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.